© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 11, 810-823,
June 6, 2001
© 2001 Oxford University Press
REVIEW |
Behavioral Intervention for Cancer Treatment Side Effects
Affiliation of authors: Program for Cancer Prevention and Control, Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, NY.
Correspondence to: William H. Redd, Ph.D., Derald H. Ruttenberg Cancer Center, Box 1130, Mount Sinai School of Medicine, 1425 Madison Ave., New York, NY 10029-6574 (e-mail: william.redd{at}mssm.edu).
The use of increasingly aggressive methods of cancer treatment during the last 20 years has brought clinical attention to the need for more effective management of pain, nausea, and other aversive side effects of state-of-the-art cancer therapy. One of the most promising approaches to effective management is nonpharmacologic intervention based on behavioral research and theory. The purpose of this review is to examine the effectiveness of behavioral intervention methods in the control of aversive side effects of cancer treatments. Fifty-four published studies using a variety of research designs were identified for review. Results indicated the following: 1) Behavioral intervention can effectively control anticipatory nausea and vomiting in adult and pediatric cancer patients undergoing chemotherapy; however, the evidence for the efficacy of behavioral intervention to control post-chemotherapy nausea and vomiting is less clear. 2) Behavioral intervention integrating several behavioral methods can ameliorate anxiety and distress associated with invasive medical treatments. 3) Although a variety of behavioral methods have been shown to reduce acute treatment-related pain, there is increasing evidence that these methods are not equally effective. Hypnotic-like methods, involving relaxation, suggestion, and distracting imagery, hold the greatest promise for pain management. Unfortunately, research is scant on the use of behavioral intervention to control prolonged pain associated with invasive medical procedures. It is clear that the application of behavioral theory and methods has an important place in the care of patients undergoing invasive cancer treatments.
This article has been cited by other articles:
![]() |
P. B. Jacobsen and H. S. Jim Psychosocial Interventions for Anxiety and Depression in Adult Cancer Patients: Achievements and Challenges CA Cancer J Clin, July 1, 2008; 58(4): 214 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Montgomery, D. H. Bovbjerg, J. B. Schnur, D. David, A. Goldfarb, C. R. Weltz, C. Schechter, J. Graff-Zivin, K. Tatrow, D. D. Price, et al. A Randomized Clinical Trial of a Brief Hypnosis Intervention to Control Side Effects in Breast Surgery Patients J Natl Cancer Inst, September 5, 2007; 99(17): 1304 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lee, S. Joffe, H. T. Kim, G. Socie, A. L. Gilman, J. R. Wingard, M. M. Horowitz, D. Cella, and K. L. Syrjala Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation Blood, October 1, 2004; 104(7): 2194 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Andersen, W. B. Farrar, D. M. Golden-Kreutz, R. Glaser, C. F. Emery, T. R. Crespin, C. L. Shapiro, and W. E. Carson III Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial J. Clin. Oncol., September 1, 2004; 22(17): 3570 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. DiGianni, H. T. Kim, K. Emmons, R. Gelman, K. J. Kalkbrenner, and J. E. Garber Complementary Medicine Use among Women Enrolled in a Genetic Testing Program Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 321 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Astin, S. L. Shapiro, D. M. Eisenberg, and K. L. Forys Mind-Body Medicine: State of the Science, Implications for Practice J Am Board Fam Med, March 1, 2003; 16(2): 131 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. DiGianni, J. E. Garber, and E. P. Winer Complementary and Alternative Medicine Use Among Women With Breast Cancer J. Clin. Oncol., September 15, 2002; 20(90001): 34s - 38. [Abstract] [Full Text] [PDF] |
||||





